The Company s a Taiwan-based company primarily engaged in the development, manufacture and provision of advanced therapies such as regenerative medical preparations and cell therapy preparations. The Company focuses on regenerative medical preparations, cell preparations, smart research and development, smart health, exosomes, gene and cell therapy. The Company has 7 cell therapy preparations in development, including acute respiratory distress syndrome (ARDS) (human clinical phase 2), pulmonary fibrosis (clinical phase 2), chronic renal failure, acute wound healing, and chronic wound healing for diabetic ulcers, degenerative arthritis, dry eye. The Company has used exosomes for commercial production of skin care products. The Company was established in 2022 and is headquartered in Taipei City, Taiwan.
Headquarters
Neihu Dist1F,No.28, Ln. 36, Xinhu 1St Rd
Taipei City; Taipei City;
Contact Details: Purchase the Bionet Therapeutics Corp. (Taipei City) (讯联细胞智药股份有限公司 (台北市)) report to view the information.
Website: http://www.bionettx.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service